Evidence map›Paper›PMID 36008491›Full record

ArticleEuropean journal of clinical pharmacology2022

Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?

Lixin Du, Zhigang Li, Peng Lan, Huayu Huang, Wende Cheng, Jun Xia

Erratum issuedAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Reply to Lixin Du et al.European journal of clinical pharmacology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lixin DuDepartment of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Zhigang LiDepartment of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Peng LanDepartment of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Huayu HuangDepartment of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Wende ChengDepartment of Pathology, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Jun XiaDepartment of Radiology, Shenzhen Second People's Hospital, Shenzhen, 518035, China. xiajun@email.szu.edu.cn.
Longgang Central Hospital · CNShenzhen Second People's Hospital · CN

Funding

Shenzhen Fundamental Research Program (Natural Science Foundations), General Programe for Fundamental Research JCYJ20210324142404012
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Myocardial InfarctionSodium-Glucose Transporter 2 InhibitorsStrokeHumansHypoglycemic AgentsSodium-Glucose Transporter 2Hypoglycemic AgentsSodium-Glucose Transporter 2Sodium-Glucose Transporter 2 Inhibitors

Identifiers

PMID36008491
OpenAlexW4293093369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.